An official website of the United States government
NIH Guide: Weekly Index for April 29, 2022
Weekly NIH Guide Notices
April 29, 2022
Policy Notices
-
AHRQ Announcement of Childcare Costs Allowance for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (F32s)
(NOT-HS-22-013)Agency for Healthcare Research and Quality
-
AHRQ Announcement of Childcare Costs Allowance for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Awards (T32) Beginning in FY2022
(NOT-HS-22-014)Agency for Healthcare Research and Quality
-
RESCINDED - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2023 Councils
(NOT-OD-22-113)National Institutes of Health
-
RESCINDED - NIH Response to Registration Issues in SAM.gov
(NOT-OD-22-119)National Institutes of Health
General Notices
-
Notice of Pre-Application Technical Assistance Webinar for RFA-OD-22-011, "Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)"
(NOT-MD-22-018)National Institute on Minority Health and Health Disparities
-
Inviting Comments and Suggestions on the Development of a Prize Competition for Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility.
(NOT-OD-22-109)National Institutes of Health
-
Request for Information (RFI): Challenges and Opportunities in Health and Science Communication Research
(NOT-RM-22-012)Office of Strategic Coordination (Common Fund)
-
Request for Information (RFI): Inviting Comments and Suggestions on the Potential Development of a Challenge Prize for Transformative Genome Editor Delivery Technologies
(NOT-RM-22-013)Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
-
Notice of Change to Award Budget and Funding Opportunity Description in RFA-CA-22-015 "Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)"
(NOT-CA-22-084)National Cancer Institute
-
Notice to Extend the 2022 Application Due Date for PAR-21-178 - "Drug Development Tools Research Grants (U01) Clinical Trial Optional"
(NOT-FD-22-011)Food and Drug Administration
-
Notice of Correction to Foreign Components for PAR-21-056: Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
(NOT-NS-22-069)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C Clinical Trial Not Allowed).
(NOT-DK-22-020)National Institute of Diabetes and Digestive and Kidney Diseases
Notices of Special Interest
-
Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA
(NOT-AA-22-012)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)
(NOT-AI-22-042)National Institute of Allergy and Infectious DiseasesNational Institute of Mental Health
-
Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection
(NOT-AI-22-043)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Administrative Supplements for Lyme Disease and other Tickborne Illnesses
(NOT-AI-22-048)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics
(NOT-CA-22-083)National Cancer Institute
-
Notice of Special Interest: Achieving Tissue Robustness Through Harnessing Immune System Plasticity
(NOT-DE-22-005)National Institute of Dental and Craniofacial Research
Funding Opportunities
-
Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
(PAR-22-146)National Institute of Neurological Disorders and StrokeNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): July 29, 2022
-
Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
(RFA-AG-23-031)National Institute on AgingApplication Receipt Date(s): October 17, 2022
-
NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed)
(RFA-AR-23-002)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): September 13, 2022
-
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional)
(RFA-DA-23-012)National Institute on Drug AbuseApplication Receipt Date(s): August 11, 2023
-
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
(RFA-DA-23-040)National Institute on Drug AbuseApplication Receipt Date(s): August 10, 2022
-
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-22-004)National Institute of Environmental Health SciencesApplication Receipt Date(s): July 29, 2022
-
Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed)
(RFA-MH-22-230)National Institute of Mental HealthApplication Receipt Date(s): Not Applicable
-
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
(RFA-RM-22-021)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): September 2, 2022
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster